Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Wiesbaden
Clinical trial register · Germany

Clinical Trials in Wiesbaden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5082 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
5082
Studies in scope
all four open statuses
2886
Recruiting now
open to new participants
989
Lead sponsors
across recruiting studies
Top sites
Berlin 1593 Hamburg 896 Essen 765 Dresden 716 Heidelberg 626

Trials with a site in Wiesbaden

26 of 5082 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
St. Josefs-Hospital Wiesbaden GmbH
Not applicable
94
Wiesbaden
2026-10-26
Recruiting
AstraZeneca
Phase 3
950
Berlin, Bonn, Düsseldorf, Hanover, Wiesbaden
2026-09-16
By invitation
Median
Not applicable
33
Wiesbaden
2026-07-07
Recruiting
Bristol-Myers Squibb
Phase 3
750
Wangen, Landshut, Rosenheim, Kaiserslautern, Langen, Wiesbaden, Cologne, Dortmund
2026-03-12
Recruiting
St. Josefs-Hospital Wiesbaden GmbH
Not applicable
86
Hagen, Wiesbaden
2026-02-01
Recruiting
Genmab
Phase 3
660
Hamburg, Wiesbaden, Bonn, Lemgo, Berlin
2025-11-28
Recruiting
Intuitive Surgical
Observational
1,200
Berlin, Hemer, Wiesbaden
2025-09-09
Recruiting
Clinical Application Observation on the Evaluation of Phantom Limb Pain With the Suralis System
NCT07324109Phantom Limb Pain After Amputation, Lower Limb Amputation Above Knee, Lower Limb Amputation Below Knee, Lower Limb Amputation Knee
Median
Not applicable
20
Wiesbaden
2025-04-01
Active, closed
Sanofi
Phase 3
231
Berlin, Frankfurt, Hamburg, Landsberg, Münster, Tübingen, Wiesbaden, Würzburg
2025-02-12
Recruiting
Hoffmann-La Roche
Phase 3
500
Bremen, Ulm, Westerstede, Wiesbaden
2024-12-13
Active, closed
AstraZeneca
Phase 3
181
Marburg, Tübingen, Villingen-Schwenningen, Wiesbaden
2024-12-03
Active, closed
DualityBio Inc.
Phase 3
541
Erlangen, Wiesbaden, Bottrop, Cologne, Witten, Dresden, Berlin
2024-01-18
Recruiting
Intuitive Surgical
Observational
1,250
Hamburg, Wiesbaden, Berlin, Bochum, Coburg, Cologne, Essen, Frankfurt am Main
2023-10-25
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
AbbVie
Phase 1
256
Wiesbaden
2023-01-11
Active, closed
Inventiva Pharma
Phase 3
1,000
Wiesbaden, Mainz, Homburg, Chemnitz, Dresden, Leipzig, Lübeck, Berlin
2021-08-19
Active, closed
Regeneron Pharmaceuticals
Observational
717
Mannheim, Berlin, Hennigsdorf, Wiesbaden, Düsseldorf, Münster, Dresden, Jena
2021-08-12
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Berlin, Göttingen, Leipzig, Lübeck, Ulm, Wiesbaden
2021-07-15
Active, closed
Hoffmann-La Roche
Phase 3
769
Dresden, Greifswald, Hanover, Leipzig, Münster, Tübingen, Ulm, Wiesbaden
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
864
Berlin, Bochum, Dresden, Kiel, Leipzig, Ulm, Wiesbaden
2020-11-26
Active, closed
Hoffmann-La Roche
Phase 3
985
Berlin, Böblingen, Dresden, Freiburg im Breisgau, München, Tübingen, Wiesbaden
2020-10-26
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Aachen, Berlin, Bonn, Düsseldorf, Hamburg, Wiesbaden, Würzburg
2019-09-16
Active, closed
Hoffmann-La Roche
Phase 3
927
Dresden, Greifswald, Stuttgart, Ulm, Westerstede, Wiesbaden
2018-05-28
Recruiting
St. Josefs-Hospital Wiesbaden GmbH
Observational
200
Wiesbaden
2018-04-01
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Chemnitz, Gauting, Heidelberg, Wiesbaden
2017-09-22
Active, closed
Eli Lilly and Company
Phase 3
493
Ludwigsburg, Ulm, München, Wiesbaden, Düsseldorf, Lübeck, Hamburg
2014-11-06
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-germany/city/wiesbaden

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,082 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Wiesbaden.

How many clinical trials are recruiting in Wiesbaden?

11 of the 26 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wiesbaden), 26 studies
PhaseStudiesRecruitingShare
Phase 316561.5%
Not applicable4315.4%
Observational4315.4%
Phase 1103.8%
Phase 2/3103.8%

Most active sponsors

Lead sponsors with the most studies (Wiesbaden)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche61
St. Josefs-Hospital Wiesbaden GmbH33
AstraZeneca21
Intuitive Surgical22
Median21
AbbVie10
Bristol-Myers Squibb11
DualityBio Inc.10
Eli Lilly and Company10
Genmab11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.